chrisvoncsefalvay/vaers-outcomes huggingface dataset:
when I received my first dose I got covid arm. I had a large rash on my right arm. It eventually went away and then came back and went away again. My 2nd dose I got in my left arm because I had a rash on my right arm.  I now have a purple splotch mark on my neck that will not go away. When I should my physician and kidney specialist they say they have no idea! Kinda freakin here. Anyways, I have pictures.Maybe because I have dioxin and agent orange contamination from where I was born the vaccine mutated , I have no clue. Anyways this rash is annoying and embarrassing.
Pain from neck down to bottom of rib cage on right side/extreme pain; Pain from neck down to bottom of rib cage on right side/extreme pain; A deep breath caused extreme pain; Pain continued across the stomach; This is a spontaneous report from a contactable consumer (patient). A 59-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in the right arm, on 04Jun2021 16:30 (Batch/Lot Number: EW0182), as dose 2, single, at age 59 years old, for COVID-19 immunisation, at a pharmacy/drug store. The patient was not pregnant at the time of vaccination. Medical history included migraine, thoracic disc degeneration, cervical dystonia, known allergies: cats, IV dye, tegaderm and "trednisone" (as reported), all from unknown dates. The patient was not diagnoswed with COVID-19 prior to vaccination. The patient did not receive any other vaccines within 4 weeks prior to BNT162B2. Concomitant medications included ubrogepant (UBRELVY); zolmitriptan; galcanezumab (EMGALITY); gabapentin, and "tiza" (as reported), all taken for unspecified indications, start and stop dates were not reported. The patient previously took imipramine and experienced allergy. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administered in the left arm, received on 14May2021 16:30 (batch/lot number: EW0167), as dose 1, single, at age 59 years old, for COVID-19 immunisation and the patient had no reaction. On 04Jun2021 21:00, the patient experienced pain from neck down to bottom of rib cage on right side/extreme pain, a deep breath caused extreme pain, and pain continued onto the left side from the neck down to the bottom of the rib cage and across the stomach with the same symptoms. The patient used heat, flu and cold medicine, with Benadryl at night. Treatment was also reported as "doctor's visit, blood work and chest x-rays". The events resulted to physician's office visit. The patient had COVID-19 nasal swab on 29May2021 which was negative. The patient underwent blood work and chest x-rays on an unspecified date with unknown results. The outcome of the events was recovering. The reporter assessed the events as non-serious.  Follow-up attempts are needed. Further information is expected.
Headache, Chills, Fatigue, Pain at injection site. Time Course: 48 hrs.
Patient received hepatitis and oral polio at noon time. She woke up at 11:00 pm with 102 degree rectal temperature. Fever lasted 72 hours at 102 degrees during day; 103 degrees while sleeping. Fever did respond to Tylenol drops. Absolutely no other symptoms. Baby was brought to doctor on 1/11/2002. Doctor did not feel fever due to shots because there is no reaction with these shots.
Patient was 16 years old at the time of the vaccination and given ID Jynneos vaccine. Patient had no adverse effects/side effects. Parent informed SQ should have been given and will be given 4 weeks later at dose #2.
Off label use; Booster; He is experiencing severe intestinal discomfort; He is having severe diarrhea; He feels like he is going to vomit, he has not vomited but feels like he should; He is in bed, felling terrible; He is in bed, felling terrible; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A male patient received BNT162b2 (BNT162B2), on 01Apr2022 as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series complete; unknown manufacturer), for Covid-19 immunization; Covid-19 vaccine (1st booster shot), for Covid-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 01Apr2022, outcome "unknown", described as "Booster"; OFF LABEL USE (non-serious) with onset 01Apr2022, outcome "unknown"; NAUSEA (non-serious) with onset Apr2022, outcome "unknown", described as "He feels like he is going to vomit, he has not vomited but feels like he should"; ABDOMINAL DISCOMFORT (non-serious) with onset Apr2022, outcome "unknown", described as "He is experiencing severe intestinal discomfort"; DIARRHOEA (non-serious) with onset Apr2022, outcome "unknown", described as "He is having severe diarrhea"; FEELING ABNORMAL (non-serious), BEDRIDDEN (non-serious) all with onset Apr2022, outcome "unknown" and all described as "He is in bed, felling terrible".  Additional Information: Reporter stated, "My husband, he is 76 (Not clarified) he got his fourth Pfizer shot on Friday. He is experiencing severe intestinal discomfort, he feels like he is going to vomit, he has not vomited but feels like he should. He is having severe diarrhea. Yesterday he was fine but today he woke up with it." Reporter was requested to reach to Doctor/Physician in case of any emergency. Reporter stated, "Meanwhile he is in bed, felling terrible and we don't even know if it is a side effect or something more serious.   QR Comment: Reporter type could not be probed hence captured by default as Consumer or other non-health professional in tab.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Woke up with a headache the day after the vaccine (0800). Took a nap about 1100. Woke up at 1230 with chills. Checked my temperature around 1400 and had a 101.1 fever. My normal temp is below 98. Around 1900 took and antihistamine, decongestant and ibuprofen (600mg). Went to bed around 2200. Fever broke during the night and woke up feeling normal on 29 oct 2021. I did not have any adverse effects from the first two shots in March 2021.
1 week after 1st dose was administered, redness, swelling and itching appeared at injection site.
Patient was sitting in chair with left arm exposed. I bent down to patient eye level and proceeded to insert syringe into left deltoid. Patient jumped as needle was inserted and plunger was slightly pressed. Syringe began to extract from left deltoid and scrape across arm as patient moved forward. Syringe was extracted during movements. Patient was still in sitting position, I stood up and properly discarded syringe. Patient arm was then cleaned, gauze was then applied with medical tape. Patient displayed no symptoms.
Client received her first dose of the Pfizer vaccine. At the end of her 15 minute post-vaccination wait period she developed a tingling at the tip of her left index finger. She was assessed by Nurse. The tingling remained at that anatomical location and did not spread. Client denied any itching, rash, tightness in her throat or difficulty swallowing. She could move and bend her left index finger without any difficulties. Examination of her skin did not reveal any rash. Her vital signs were as follows: BP=139/83; Pulse=74bpm; Respirations=18per minute. She was observed for 30 minutes, during which time she stated that she felt fine.
SIMILAR THINGS HAPPENING; This spontaneous report received from a consumer concerned multiple patients. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number were not reported) dose, start therapy date were not reported for covid-19 prophylaxis. The batch number was not reported and has been requested. No concomitant medications were reported. On an unspecified date, the patient experienced similar things happening. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of similar things happening was not reported. This report was non-serious. This case, from the same reporter is linked to 20230258457.
Called after vaccine administered around 7:20 pm stating she felt tingling in the lips. Patient took BENADRYL. At some point she passed out and an Ambulance took her to the hospital. After many attempts to contact patient for more info, unsuccessful.
Acute urticaria. Pt described as the rash began the after the vaccine it was on both legs and arms. It itched and turned into hives.
Received vaccine at 11:45 am on October 30.  Around 1 or 1:30 pm felt like something lodged in throat, followed by tightness in chest and racing heart.  Wasn't sure if it was a reaction, but it got worse and was followed by diarrhea and nausea, and asthma attack.  By 3:30 pm I collapsed in bathroom and coworkers called an ambulance to take me to ER.  I was given anti-nausea medicine en route and at ER.  After meeting with doctor and tests administered, including EKG and blood tests, I was given Benadryl and the throat felt better.  I was also prescribed Prednisone for 5 days.  I left the ER at about 7 pm.  I had to go back to ER at around 11pm due to stomach pains and fever of 101.  I wasn't seen until after 1 am and they did a cat scan of stomach area and found nothing wrong and determined it was probably more of the allergic reaction, so I left at around 2:30 am.  11/2/07 Received t/c from patient/reporter.  States she is feeling somewhat better & able to return to work partial day.  Still on steroids & benadryl.  Has appt w/allergist next week as she has had flu shots many times in past w/o any problems.  11/30/07 Reviewed ER medical records which reveal patient experienced gradual onset of throat tightness & abdominal pain & cramps beginning several hours after flu vax. She had an asthma attack w/subsequent SOB, wheezing & dry cough followed by nausea, diarrhea, malaise & weakness.  Had received flu shots in past w/o problems.  Tx w/antihistamine & symptoms completely resolved.  D/C to home but returned to ER 7 hours later w/worsening RLQ abdominal pain & temp of 101 w/urinary frequency & decreased UO. FINAL DX: acute allergic reaction to influenza vaccine & RLQ abdominal pain, resolving. Per 60 day follow up I had allergy tests done after this event to see if I had afood allergy but everything came back negative so it must have been the flu shot only that caused it.  Follow-up Information 14-NOV-2008: Abstaining from flu shots indefinitely.
My mom and my dad they were vaccinated and they caught COVID too; My mom and my dad they were vaccinated and they caught COVID too; This is a spontaneous report from a contactable consumer. A female patient of an unspecified age received BNT162B2 (Solution for injection), via an unspecified route of administration on an unspecified date (Batch/Lot number: unknown) at single dose for covid-19 immunisation (unspecified age at vaccination). The patient's medical history was not reported. Concomitant medication included phenytoin (DILANTIN [PHENYTOIN]) taken for an unspecified indication. Patient called in seeking assistance with the medication Dilantin. The patient was vaccinated with the Pfizer shot and took first dose and tested positive for COVID and her mom and dad they were vaccinated and they caught COVID too everything that I read it says the vaccination don't give you, you can't get COVID from being vaccinated. We were vaccinated the first time and we've all come down with COVID we all tested positive. Her father doctor told him he don't need to be vaccinated no more cause her dad has cancer and she read that Pfizer did not test the drug on cancer patient's, the vaccine. She heard from doctor's office that were not the only people that's getting vaccinated and then test for COVID. They told that she was probably was already exposed to it, and doing fine and then went to take shot take all of a sudden started feeling bad and went to take the test and was positive. She was looking forward to going back to work and had been off of work since the 15Feb. She could not go back to work until she tested Negative. The patient underwent lab tests and procedures which included COVID test: positive on an unspecified date. Outcome of the events was unknown.     Follow-up attempts are completed. No further information is expected.
This spontaneous report as received from a healthcare worker, office manager and medical assistant refers to a patient of unknown age and gender. Medical history and concurrent conditions were not provided. On 18-MAR-2015, the patient was vaccinated with a expired dose of ZOSTAVAX lot number K000996, expiry date 13-MAR-2015 (dose and route were not reported). No adverse effect had been observed or reported. There was no concomitant medication provided. Additional information has been requested.
Information has been received from the registered nurse on 02-JAN-2014. It was reported that GARDASIL vaccines were stored in improper temperatures and were administered to overall number of 132 patients. This report refers to one of the patients involved: a patient of unspecified age and gender, who was administered dose of GARDASIL on 23-AUG-2013 (lot # H021608, Expiration Date: 13-AUG-2015). No adverse event was reported. This is one of the report from the same source. Additional information is not expected.
Headache-coupe hours after shot through next day. Fever  & Chills  about 12 hours after shot 11:30pm - 4:00 am
fever, swelling at administration site, H/A, myalgia, arthragia, malaise, chills, nausea, decreased limb mobility
After receiving her vaccination at approximately 11am patient complained about numbness in her left arm and left leg. She later experienced dizziness and lightheadedness and laid down for approximately half an hour before feeling well enough to walk to her car and be driven home.
Information has been received from a physician concerning a 26 year old female patient who on 25-APR-2007 was vaccinated IM in the left deltoid with her second dose of Gardasil. On the Friday after the injection, 27-APR-2007, swelling and bruising appeared at the injection site. On the Saturday after the injection, the injection site began to bleed. The patient stopped the bleeding with a compress and sought medical attention. She was fully recovered on an unspecified date. Additional information has been requested. Follow up information has been received concerning the medical assistant who at 8:20 a.m. on 15-APR-2007 was vaccinated IM in left deltoid with her second dose of GARDASIL. Two days after the injection the injection site was very sore and started to bleed. It was reorted that the injection site remained sore and bruised looking. Additional information is not expected.
adult patient received a pediatric dose of Engerix B; adult patient received a pediatric dose of Engerix B; This non-serious case was reported by a other health professional via call center representative and described the occurrence of underdose in a 24-year-old female patient who received HBV (Engerix B pediatric) (batch number 9PG49, expiry date 28-DEC-2024) for prophylaxis.   On 17-MAY-2023, the patient received the 1st dose of Engerix B pediatric. On 17-MAY-2023, an unknown time after receiving Engerix B pediatric, the patient experienced underdose (Verbatim: adult patient received a pediatric dose of Engerix B) and adult use of a child product (Verbatim: adult patient received a pediatric dose of Engerix B). The outcome of the underdose and adult use of a child product were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 24-May-2023 The reporter was medical assistant. The vaccine administration facility was the same as primary reporter. The reporter did not consent to follow-up. An adult patient received a dose of Engerix-B pediatric, which led to underdose and adult use of a child product.
I received the vaccine on Thursday (11/11/21) at 0905. I went to sleep that night and woke up sometime in the middle of the night with chills but no fever, muscle aches over a good portion of my body, a sore left arm and a headache. The totality of the symptoms lasted until sometime Saturday morning (11/13/21) as I slept, with the symptoms varying at different levels throughout that time frame.
a little sore and right arm was sore; a little sore and right arm was sore; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (a little sore and right arm was sore) and MYALGIA (a little sore and right arm was sore) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for an unknown indication.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE PAIN (a little sore and right arm was sore) and MYALGIA (a little sore and right arm was sore). At the time of the report, VACCINATION SITE PAIN (a little sore and right arm was sore) and MYALGIA (a little sore and right arm was sore) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       This case was linked to MOD-2021-114954 (Patient Link).
This spontaneous report as received from a licensed practical nurse refers to a 50 year old female patient with drug allergy to erythromycin, drug allergy to penicillin and pulmonary fibrosis. The patient had received PNEUMOVAX 23 on an unspecified date 10 years ago (approximately October 2004) with no ill effect. On 16-OCT-2014 the patient was vaccinated with PNEUMOVAX 23 (lot # J011799, exp 09-FEB-2015) in the right arm (dose#, dose and route not reported). The patient also received an unspecified flu vaccine on 16-OCT-2014 in her left arm. The patient had soreness at the injection site of the PNEUMOVAX 23 on 16-OCT-2014. The next day, 17-OCT-2014, there was redness and pain at the injection site of the PNEUMOVAX 23. The patient did not seek medical attention and was coming to the unspecified physician's office today for assessment. The patient stated that the arm had a large blister at the site of injection of the PNEUMOVAX 23. The patient stated that there was no more pain however there was a large unspecified blister. No treatment given to these events. The outcome of redness at the injection site of the PNEUMOVAX 23 was reported as not recovered/not resolved. Additional information has been requested.
I felt fatigued which lasted throughout the day.; This is a spontaneous report from a contactable consumer reporting on herself. A 55-years-old non-pregnant female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route, administered in left arm on 15Feb2021 08:30 (Batch/Lot Number: EL3247, expiration date not reported) as SINGLE DOSE for COVID-19 immunization. Patient medical history was not reported. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration, administered in left arm on 26Jan2021 08:45 (Batch/Lot Number: EL3247, expiration date not reported) as SINGLE DOSE for COVID-19 immunization. Concomitant medication included clonazepam. The patient did not receive any other vaccines in four weeks, and she did not have COVID prior vaccination. The patient did not test COVID post vaccination. On 16Feb2021 at 08:00 Approximately 24 hours after receiving the vaccine, the patient felt fatigued which lasted throughout the day. The patient did not receive any treatment for the event. The following day she felt fine and recovered on 17Feb2021.   Information about lot/batch number has been requested.
strained his back.; back pain; This is a spontaneous report received from a non-contactable consumer from Medical information team for a Pfizer sponsored program (159558). The reporter is the patient.  A male patient received bnt162b2 (COMIRNATY), administration date 23Jun2021 (Batch/Lot number: unknown) as dose 2, single for COVID-19 immunisation. Relevant medical history included: "disc issues of the lumbar back and in his back" (unspecified if ongoing); "back issues" (unspecified if ongoing); "lung issues" (unspecified if ongoing); "asthma" (unspecified if ongoing); "psoriasis" (unspecified if ongoing). The patient's concomitant medications were not reported. Vaccination history included: COVID-19 vaccine (dose 1, manufacturer unknown), administration date: 02Jun2021, for COVID-19 Immunization, reaction(s): "asthma with lung issues.", "asthma with lung issues.", "Left leg started aching", "disc issues/Back disc issues.", "heart diseases", "back pain". The following information was reported: MUSCLE STRAIN (non-serious) with onset 2021, outcome "unknown", described as "strained his back."; BACK PAIN (non-serious) with onset 2021, outcome "unknown", described as "back pain". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: The patient was asking if he needs to be tested as he experienced back pain, indicated by healthcare professional as not related. The patient strained his back. The healthcare professional recommended him to get booster dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
After about 2 weeks from first dose I experienced Dizzyness, lightheadedness, shortness of breath. Nausea.
My heart rate went up 147 heart rate and stayed high for 48hours; fatigue; chills; fever 101 lasted 24hours and came down to a 100 to a couple of days; headache; general body pains; joint pains.
Vaccine was expired upon administration.  Vaccine was thawed and refrigerated starting on 8/26/2022 at 11:15 a.m. and expired on 9/25/2022 at 11:15 a.m.  Dose was administered on 9/26/2022 at 09:00 a.m.    Patient was unharmed and did not show any signs or symptoms of distress.  Patient was notified of expired medication and is currently awaiting follow-up instructions.
complained at 11:00 am, approximately 24 hours after vaccination ,that is tongue was swelling.  took 2 Benadryl.  At 430 pm tongue still swollen. Took 2 Benadryl.  At 545pm tongue still swollen and called care.  was seen at care and was prescribed prednisone.  saw his primary care physician next day Monday April 12th.
Menveo / reconstituted with Non-approved Diluent / administered to a patient; Menveo / reconstituted with Non-approved Diluent / administered to a patient; This case was reported by a other health professional via call center representative and described the occurrence of wrong solution used in drug reconstitution in a 11-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA436A, expiry date 31st October 2021) for prophylaxis.   On 15th April 2021, the patient received Menveo. On 15th April 2021, unknown after receiving Menveo, the patient experienced wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. On an unknown date, the outcome of the wrong solution used in drug reconstitution and inappropriate dose of vaccine administered were unknown.  Additional information was provided as follows:  The patient received Menveo which was reconstituted with sterile diluent instead of correct diluent, which led to wrong solution used in drug reconstitution and inappropriate dose of vaccine administered. Office Manager confirmed and reported Menveo Lyophilized Powder was reconstituted with non-approved Diluent and then administered to the patient.  The reporter did not consent to follow up.